Carcinogenic human papillomavirus infection
Infections with human papillomavirus (HPV) are common and transmitted by direct contact.
Although the great majority of infections resolve within 2 years, 13 phylogenetically related …
Although the great majority of infections resolve within 2 years, 13 phylogenetically related …
Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income …
Summary Background The WHO Director-General has issued a call for action to eliminate
cervical cancer as a public health problem. To help inform global efforts, we modelled …
cervical cancer as a public health problem. To help inform global efforts, we modelled …
Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries
Background WHO is developing a global strategy towards eliminating cervical cancer as a
public health problem, which proposes an elimination threshold of four cases per 100 000 …
public health problem, which proposes an elimination threshold of four cases per 100 000 …
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
This article provides an update on the global cancer burden using the GLOBOCAN 2020
estimates of cancer incidence and mortality produced by the International Agency for …
estimates of cancer incidence and mortality produced by the International Agency for …
Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020–99: a …
Background Cervical screening and human papillomavirus (HPV) vaccination have been
implemented in most high-income countries; however, coverage is low in low-income and …
implemented in most high-income countries; however, coverage is low in low-income and …
Cost-effectiveness of human papillomavirus vaccination in low and middle income countries: a systematic review
M Fesenfeld, R Hutubessy, M Jit - Vaccine, 2013 - Elsevier
Abstract The World Health Organization recommends establishing that human
papillomavirus vaccination is cost-effective before vaccine introduction. We searched …
papillomavirus vaccination is cost-effective before vaccine introduction. We searched …
Benefits, harms and cost-effectiveness of cervical screening, triage and treatment strategies for women in the general population
Abstract In 2020, the World Health Organization (WHO) launched a strategy to eliminate
cervical cancer as a public health problem. To support the strategy, the WHO published …
cervical cancer as a public health problem. To support the strategy, the WHO published …
[HTML][HTML] Impact of HPV vaccine hesitancy on cervical cancer in Japan: a modelling study
Background Funding for human papillomavirus (HPV) vaccination in Japan began in 2010
for girls aged 12–16 years, with three-dose coverage initially reaching more than 70%. On …
for girls aged 12–16 years, with three-dose coverage initially reaching more than 70%. On …
Domestic HPV vaccine price and economic returns for cervical cancer prevention in China: a cost-effectiveness analysis
Background Coinciding with the release of the first Chinese domestic human papillomavirus
(HPV) vaccine Cecolin in 2019, and the substantial advancements in cervical cancer …
(HPV) vaccine Cecolin in 2019, and the substantial advancements in cervical cancer …
Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment …
Summary Background Australia's National Cervical Screening Program currently
recommends cytological screening every 2 years for women aged 18–69 years. Human …
recommends cytological screening every 2 years for women aged 18–69 years. Human …